{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T20:05:14Z","timestamp":1793390714965,"version":"4.5.0"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,9]],"date-time":"2023-11-09T00:00:00Z","timestamp":1699488000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.jconrel.2023.11.006","type":"journal-article","created":{"date-parts":[[2023,11,8]],"date-time":"2023-11-08T17:57:57Z","timestamp":1699466277000},"page":"458-472","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"special_numbering":"C","title":["Extracellular vesicles encapsulated with caspase-1 inhibitor ameliorate experimental autoimmune myasthenia gravis through targeting macrophages"],"prefix":"10.1016","volume":"364","author":[{"given":"Yang","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Lin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Li","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Yue","family":"Si","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui-Sheng","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cong-Cong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2023.11.006_bb0005","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1056\/NEJMra1602678","article-title":"Myasthenia gravis","volume":"375","author":"Gilhus","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2023.11.006_bb0010","doi-asserted-by":"crossref","first-page":"E1141","DOI":"10.1503\/cmaj.180656","article-title":"Myasthenia gravis","volume":"190","author":"Bourque","year":"2018","journal-title":"CMAJ"},{"key":"10.1016\/j.jconrel.2023.11.006_bb0015","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/nyas.13591","article-title":"An imbalance between regulatory T cells and T helper 17 cells in acetylcholine receptor-positive myasthenia gravis patients","volume":"1413","author":"Villegas","year":"2018","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jconrel.2023.11.006_bb0020","doi-asserted-by":"crossref","first-page":"2610","DOI":"10.4049\/jimmunol.1500725","article-title":"Augmentation of circulating follicular helper T cells and their impact on autoreactive B cells in myasthenia gravis","volume":"197","author":"Zhang","year":"2016","journal-title":"J. Immunol."},{"key":"10.1016\/j.jconrel.2023.11.006_bb0025","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/s41582-018-0110-z","article-title":"Immunotherapy in myasthenia gravis in the era of biologics","volume":"15","author":"Dalakas","year":"2019","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.jconrel.2023.11.006_bb0030","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.cyto.2015.06.011","article-title":"Elevated plasma interleukin-17A in a subgroup of Myasthenia Gravis patients","volume":"78","author":"Xie","year":"2016","journal-title":"Cytokine"},{"key":"10.1016\/j.jconrel.2023.11.006_bb0035","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s12264-019-00344-1","article-title":"Enhancement of T follicular helper cell-mediated humoral immunity reponses during development of experimental autoimmune myasthenia gravis","volume":"35","author":"Cui","year":"2019","journal-title":"Neurosci. Bull."},{"key":"10.1016\/j.jconrel.2023.11.006_bb0040","doi-asserted-by":"crossref","first-page":"e826","DOI":"10.1111\/j.1365-2567.2009.03089.x","article-title":"Disequilibrium of T helper type 1, 2 and 17 cells and regulatory T cells during the development of experimental autoimmune myasthenia gravis","volume":"128","author":"Mu","year":"2009","journal-title":"Immunology"},{"key":"10.1016\/j.jconrel.2023.11.006_bb0045","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s00281-015-0494-4","article-title":"Caspase-1: an integral regulator of innate immunity","volume":"37","author":"Winkler","year":"2015","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.jconrel.2023.11.006_bb0050","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.cell.2014.04.007","article-title":"Mechanisms and functions of inflammasomes","volume":"157","author":"Lamkanfi","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.jconrel.2023.11.006_bb0055","doi-asserted-by":"crossref","first-page":"11541","DOI":"10.1038\/ncomms11541","article-title":"Experimental priming of encephalitogenic Th1\/Th17 cells requires pertussis toxin-driven IL-1beta production by myeloid cells","volume":"7","author":"Ronchi","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2023.11.006_bb0060","doi-asserted-by":"crossref","first-page":"E6065","DOI":"10.1073\/pnas.1722041115","article-title":"Caspase-1 inhibition prevents glial inflammasome activation and pyroptosis in models of multiple sclerosis","volume":"115","author":"McKenzie","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2023.11.006_bb0065","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1124\/jpet.106.111344","volume":"321","author":"Wannamaker","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jconrel.2023.11.006_bb0070","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1189\/jlb.3MR0516-224R","article-title":"Caspase-1 as a multifunctional inflammatory mediator: noncytokine maturation roles","volume":"100","author":"Sun","year":"2016","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.jconrel.2023.11.006_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.envint.2020.105706","article-title":"Phthalate exposure and allergic diseases: review of epidemiological and experimental evidence","volume":"139","author":"Bolling","year":"2020","journal-title":"Environ. Int."},{"key":"10.1016\/j.jconrel.2023.11.006_bb0080","doi-asserted-by":"crossref","DOI":"10.1126\/science.aau6977","article-title":"The biology, function, and biomedical applications of exosomes","volume":"367","author":"Kalluri","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2023.11.006_bb0085","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41556-018-0250-9","article-title":"Specificities of secretion and uptake of exosomes and other extracellular vesicles for cell-to-cell communication","volume":"21","author":"Mathieu","year":"2019","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.jconrel.2023.11.006_bb0090","doi-asserted-by":"crossref","first-page":"3040","DOI":"10.1021\/acs.nanolett.9b00287","article-title":"Reversal of osteoporotic activity by endothelial cell-secreted bone targeting and biocompatible Exosomes","volume":"19","author":"Song","year":"2019","journal-title":"Nano Lett."},{"key":"10.1016\/j.jconrel.2023.11.006_bb0095","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.addr.2020.04.004","article-title":"Extracellular vesicles as drug delivery systems: why and how?","volume":"159","author":"Elsharkasy","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2023.11.006_bb0100","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/j.nano.2017.03.001","article-title":"Milk-derived exosomes for oral delivery of paclitaxel","volume":"13","author":"Agrawal","year":"2017","journal-title":"Nanomedicine"},{"key":"10.1016\/j.jconrel.2023.11.006_bb0105","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.carbpol.2018.08.141","article-title":"pH-responsive hyaluronate-anchored extracellular vesicles to promote tumor-targeted drug delivery","volume":"202","author":"Lee","year":"2018","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.jconrel.2023.11.006_bb0110","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/nbt.1807","article-title":"Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes","volume":"29","author":"Alvarez-Erviti","year":"2011","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2023.11.006_bb0115","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jconrel.2015.03.033","article-title":"Exosomes as drug delivery vehicles for Parkinson\u2019s disease therapy","volume":"207","author":"Haney","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2023.11.006_bb0120","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s12974-015-0334-4","article-title":"Caspase-1 inhibitor ameliorates experimental autoimmune myasthenia gravis by innate dendric cell IL-1-IL-17 pathway","volume":"12","author":"Wang","year":"2015","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.jconrel.2023.11.006_bb0125","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.neulet.2017.05.040","article-title":"Caspase-1 inhibitor regulates humoral responses in experimental autoimmune myasthenia gravis via IL-6- dependent inhibiton of STAT3","volume":"656","author":"Wang","year":"2017","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.jconrel.2023.11.006_bb0130","doi-asserted-by":"crossref","first-page":"789","DOI":"10.7150\/thno.18133","article-title":"Progress in exosome isolation techniques","volume":"7","author":"Li","year":"2017","journal-title":"Theranostics"},{"key":"10.1016\/j.jconrel.2023.11.006_bb0135","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s12974-016-0475-0","article-title":"Exosomes derived from atorvastatin-modified bone marrow dendritic cells ameliorate experimental autoimmune myasthenia gravis by up-regulated levels of IDO\/Treg and partly dependent on FasL\/Fas pathway","volume":"13","author":"Li","year":"2016","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.jconrel.2023.11.006_bb0140","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/s41596-019-0236-5","article-title":"Analyzing bacterial extracellular vesicles in human body fluids by orthogonal biophysical separation and biochemical characterization","volume":"15","author":"Tulkens","year":"2020","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.jconrel.2023.11.006_bb0145","doi-asserted-by":"crossref","first-page":"5738","DOI":"10.4049\/jimmunol.1003597","article-title":"Caspase-1\u2013processed cytokines IL-1\u03b2 and IL-18 promote IL-17 production by \u03b3\u03b4 and CD4 T cells that mediate autoimmunity","volume":"186","author":"Lalor","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.jconrel.2023.11.006_bb0150","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.immuni.2011.03.023","article-title":"ICOS receptor instructs T follicular helper cell versus effector cell differentiation via induction of the transcriptional repressor Bcl6","volume":"34","author":"Choi","year":"2011","journal-title":"Immunity"},{"key":"10.1016\/j.jconrel.2023.11.006_bb0155","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.immuni.2015.01.017","article-title":"ICOS coreceptor signaling inactivates the transcription factor FOXO1 to promote Tfh cell differentiation","volume":"42","author":"Stone","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.jconrel.2023.11.006_bb0160","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1084\/jem.20141432","article-title":"ICOS maintains the T follicular helper cell phenotype by down-regulating Kruppel-like factor 2","volume":"212","author":"Weber","year":"2015","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jconrel.2023.11.006_bb0165","article-title":"Interleukin-1 (IL-1) pathway","volume":"3","author":"Weber","year":"2010","journal-title":"Sci. Signal."},{"key":"10.1016\/j.jconrel.2023.11.006_bb0175","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.12085","article-title":"Biodistribution of extracellular vesicles following administration into animals: a systematic review","volume":"10","author":"Kang","year":"2021","journal-title":"J. Extracellular Vesicles"},{"key":"10.1016\/j.jconrel.2023.11.006_bb0180","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/s41565-021-00931-2","article-title":"Extracellular vesicles as a next-generation drug delivery platform","volume":"16","author":"Herrmann","year":"2021","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2023.11.006_bb0185","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2023.1211833","article-title":"Biodelivery of therapeutic extracellular vesicles: should mononuclear phagocytes always be feared?","volume":"11","author":"Cie\u015blik","year":"2023","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.jconrel.2023.11.006_bb0195","doi-asserted-by":"crossref","DOI":"10.3402\/jev.v4.26316","article-title":"Extracellular vesicle in vivo biodistribution is determined by cell source, route of administration and targeting","volume":"4","author":"Wiklander","year":"2015","journal-title":"J. Extracellular Vesicles"},{"key":"10.1016\/j.jconrel.2023.11.006_bb0200","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2018.00735","article-title":"The advances and challenges in utilizing exosomes for delivering cancer therapeutics","volume":"9","author":"Yang","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jconrel.2023.11.006_bb0205","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s11481-019-09884-9","article-title":"Macrophage-derived extracellular vesicles as drug delivery systems for Triple Negative Breast Cancer (TNBC) therapy","volume":"15","author":"Haney","year":"2020","journal-title":"J. NeuroImmune Pharmacol."},{"key":"10.1016\/j.jconrel.2023.11.006_bb0210","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.actbio.2019.10.022","article-title":"Gemcitabine loaded autologous exosomes for effective and safe chemotherapy of pancreatic cancer","volume":"101","author":"Li","year":"2020","journal-title":"Acta Biomater."},{"key":"10.1016\/j.jconrel.2023.11.006_bb0220","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.nano.2015.10.012","article-title":"Development of exosome-encapsulated paclitaxel to overcome MDR in cancer cells","volume":"12","author":"Kim","year":"2016","journal-title":"Nanomedicine"},{"key":"10.1016\/j.jconrel.2023.11.006_bb0225","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1038\/aps.2017.12","article-title":"Engineering exosomes as refined biological nanoplatforms for drug delivery","volume":"38","author":"Luan","year":"2017","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.jconrel.2023.11.006_bb0230","doi-asserted-by":"crossref","first-page":"8489251","DOI":"10.1155\/2016\/8489251","article-title":"Double roles of macrophages in human neuroimmune diseases and their animal models","volume":"2016","author":"Fan","year":"2016","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.jconrel.2023.11.006_bb0235","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1212\/WNL.35.10.1455","article-title":"Use of monoclonal antiacetylcholine receptor antibodies to investigate the macrophage inflammation of acute experimental myasthenia gravis: refractoriness to a second episode of acute disease","volume":"35","author":"Corey","year":"1985","journal-title":"Neurology"},{"key":"10.1016\/j.jconrel.2023.11.006_bb0240","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1111\/febs.13998","article-title":"Caspase-1 promotes monocyte-macrophage differentiation by repressing PPARgamma","volume":"284","author":"Niu","year":"2017","journal-title":"FEBS J."},{"key":"10.1016\/j.jconrel.2023.11.006_bb0245","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1146\/annurev.immunol.021908.132612","article-title":"Immunological and inflammatory functions of the interleukin-1 family","volume":"27","author":"Dinarello","year":"2009","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2023.11.006_bb0250","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/nri1807","article-title":"Diversification of T-helper-cell lineages: finding the family root of IL-17-producing cells","volume":"6","author":"Dong","year":"2006","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2023.11.006_bb0255","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/nri.2017.50","article-title":"The dichotomous nature of T helper 17 cells","volume":"17","author":"Stockinger","year":"2017","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2023.11.006_bb0260","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaut.2017.12.007","article-title":"A cellular and molecular view of T helper 17 cell plasticity in autoimmunity","volume":"87","author":"Stadhouders","year":"2018","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jconrel.2023.11.006_bb0265","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/ni.2416","article-title":"Induction and molecular signature of pathogenic TH17 cells","volume":"13","author":"Lee","year":"2012","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jconrel.2023.11.006_bb0270","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.immuni.2017.11.023","article-title":"Precursor frequency and affinity determine B cell competitive fitness in germinal centers, tested with germline-targeting HIV vaccine immunogens","volume":"48","author":"Abbott","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.jconrel.2023.11.006_bb0275","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/s41577-019-0244-2","article-title":"B cell memory: building two walls of protection against pathogens","volume":"20","author":"Akkaya","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2023.11.006_bb0280","doi-asserted-by":"crossref","first-page":"333","DOI":"10.3109\/08916934.2012.665524","article-title":"Germinal center B-cells","volume":"45","author":"Hamel","year":"2012","journal-title":"Autoimmunity"},{"key":"10.1016\/j.jconrel.2023.11.006_bb0285","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1146\/annurev-immunol-041015-055605","article-title":"Follicular helper T cells","volume":"34","author":"Vinuesa","year":"2016","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2023.11.006_bb0290","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/j.immuni.2019.04.011","article-title":"T follicular helper cell biology: a decade of discovery and diseases","volume":"50","author":"Crotty","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.jconrel.2023.11.006_bb0295","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/cei.13546","article-title":"Roles of cytokines and T cells in the pathogenesis of myasthenia gravis","volume":"203","author":"Uzawa","year":"2021","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jconrel.2023.11.006_bb0300","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jneuroim.2012.12.001","article-title":"Expansion of circulating counterparts of follicular helper T cells in patients with myasthenia gravis","volume":"256","author":"Luo","year":"2013","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jconrel.2023.11.006_bb0305","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.immuni.2010.12.012","article-title":"Human blood CXCR5(+)CD4(+) T cells are counterparts of T follicular cells and contain specific subsets that differentially support antibody secretion","volume":"34","author":"Morita","year":"2011","journal-title":"Immunity"},{"key":"10.1016\/j.jconrel.2023.11.006_bb0310","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1136\/annrheumdis-2019-215195","article-title":"Potential involvement of OX40 in the regulation of autoantibody sialylation in arthritis","volume":"78","author":"Kurata","year":"2019","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jconrel.2023.11.006_bb0315","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.4049\/jimmunol.1900955","article-title":"Fingolimod profoundly reduces frequencies and alters subset composition of circulating T follicular helper cells in multiple sclerosis patients","volume":"204","author":"Huber","year":"2020","journal-title":"J. Immunol."},{"key":"10.1016\/j.jconrel.2023.11.006_bb0320","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.3389\/fimmu.2019.02686","article-title":"The balance in T follicular helper cell subsets is altered in neuromyelitis optica spectrum disorder patients and restored by rituximab","volume":"10","author":"Nicolas","year":"2019","journal-title":"Front. Immunol."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016836592300723X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016836592300723X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T16:53:38Z","timestamp":1759164818000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016836592300723X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":61,"alternative-id":["S016836592300723X"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2023.11.006","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Extracellular vesicles encapsulated with caspase-1 inhibitor ameliorate experimental autoimmune myasthenia gravis through targeting macrophages","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2023.11.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}